Skip to main content
Top
Published in: Archives of Dermatological Research 2/2023

21-03-2022 | Metastasis | Review

Lower lip basal cell and squamous cell carcinomas: a reappraisal of the similarities and differences in clinical presentation and management

Authors: Jacqueline R. Hwang, Amor Khachemoune

Published in: Archives of Dermatological Research | Issue 2/2023

Login to get access

Abstract

Basal cell carcinoma and squamous cell carcinoma are the two most common types of carcinomas, affecting a total of 5.4 million people each year in the United States. Sun-exposed areas, especially the face and nose, are most affected given the strong association between these carcinomas and ultraviolet radiation. Less research has been done surrounding carcinomas of the lip, despite the significant aesthetic and functional importance of this area. Although lip carcinomas tend to follow a classic, unique distribution pattern that favors basal cell carcinoma on the upper lip and squamous cell carcinoma on the lower lip, more cases of lower lip basal cell carcinoma are being reported, warranting further educational awareness to differentiate carcinomas of the lower lip. In this article, we provide an updated overview of the risk factors, presentations, differential diagnoses, metastatic risks, evaluation, management guidelines, and outcomes of lower lip carcinoma. Of note, recent advances in imaging modalities are beginning to show promise as a non-invasive, affordable, and rapid way to detect and stage tumors. We conclude that increased clinical awareness and investigation of lower lip carcinoma is needed to improve early intervention, as a delayed diagnosis can rapidly alter the management and outcomes of lip carcinomas.
Literature
6.
go back to reference Kricker A, Armstrong BK (1995) English DR Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer 60(4):489–494CrossRefPubMed Kricker A, Armstrong BK (1995) English DR Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer 60(4):489–494CrossRefPubMed
21.
go back to reference Hays JP, Malone CH, Tausend WE, Goodwin BP, Wagner RF Jr (2017) Delayed diagnosis of basal cell carcinoma of the upper lip: the possible role of incidental multinucleated foreign body giant cells. Case Rep Dermatol 9:50–54CrossRefPubMedPubMedCentral Hays JP, Malone CH, Tausend WE, Goodwin BP, Wagner RF Jr (2017) Delayed diagnosis of basal cell carcinoma of the upper lip: the possible role of incidental multinucleated foreign body giant cells. Case Rep Dermatol 9:50–54CrossRefPubMedPubMedCentral
26.
go back to reference von Domarus H, Stevens PJ (1984) Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10(6):1043–1060CrossRef von Domarus H, Stevens PJ (1984) Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10(6):1043–1060CrossRef
27.
go back to reference Moretti A, Vitullo F, Augurio A, Pacella A, Croce A (2011) Surgical management of lip cancer. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 31(1):5–10PubMed Moretti A, Vitullo F, Augurio A, Pacella A, Croce A (2011) Surgical management of lip cancer. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 31(1):5–10PubMed
29.
go back to reference Knuutila JS, Riihila P, Kurki S, Nissinen L, Kahari VM (2020) Risk factors and prognosis for metastatic cutaneous squamous cell carcinoma: a cohort study. Acta Derm Venereol 100(6):ADV00266CrossRefPubMed Knuutila JS, Riihila P, Kurki S, Nissinen L, Kahari VM (2020) Risk factors and prognosis for metastatic cutaneous squamous cell carcinoma: a cohort study. Acta Derm Venereol 100(6):ADV00266CrossRefPubMed
32.
44.
go back to reference Inc. Regeneron Pharmaceuticals and sanofi-aventis U.S. LLC., “LIBTAYO (cemiplimab-rwlc) injection full U.S. prescribing information,” 2021 Inc. Regeneron Pharmaceuticals and sanofi-aventis U.S. LLC., “LIBTAYO (cemiplimab-rwlc) injection full U.S. prescribing information,” 2021
52.
go back to reference Bozan N, Cankaya H, Kiroglu AF, Kocak OF, Gur MH, Erten R (2016) Lip cancer: A 16-year retrospective epidemiological study in Eastern part of Turkey. J Pakist Med Assoc 66(11):1433–1435 Bozan N, Cankaya H, Kiroglu AF, Kocak OF, Gur MH, Erten R (2016) Lip cancer: A 16-year retrospective epidemiological study in Eastern part of Turkey. J Pakist Med Assoc 66(11):1433–1435
Metadata
Title
Lower lip basal cell and squamous cell carcinomas: a reappraisal of the similarities and differences in clinical presentation and management
Authors
Jacqueline R. Hwang
Amor Khachemoune
Publication date
21-03-2022
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 2/2023
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-022-02345-z

Other articles of this Issue 2/2023

Archives of Dermatological Research 2/2023 Go to the issue